Lerman C - Search Results

1

Changes in food reward following smoking cessation: a pharmacogenetic investigation.

Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine SL, Leonard DG, Shields PG, Epstein LH. Lerman C, et al. Psychopharmacology (Berl). 2004 Aug;174(4):571-7. doi: 10.1007/s00213-004-1823-9. Epub 2004 Apr 27. Psychopharmacology (Berl). 2004. PMID: 15138759 Clinical Trial.

2

Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking.

Lerman C, Shields PG, Main D, Audrain J, Roth J, Boyd NR, Caporaso NE. Lerman C, et al. Pharmacogenetics. 1997 Dec;7(6):521-4. doi: 10.1097/00008571-199712000-00012. Pharmacogenetics. 1997. PMID: 9429239 No abstract available.

3

Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene.

Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG. Lerman C, et al. Health Psychol. 1998 Jan;17(1):56-62. doi: 10.1037//0278-6133.17.1.56. Health Psychol. 1998. PMID: 9459071

4

The role of the serotonin transporter gene in cigarette smoking.

Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR, Caporaso N. Lerman C, et al. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):253-5. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9521442

5

Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians.

Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR, Caporaso NE. Shields PG, et al. Among authors: lerman c. Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):453-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9641486

6

Evidence suggesting the role of specific genetic factors in cigarette smoking.

Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. Lerman C, et al. Health Psychol. 1999 Jan;18(1):14-20. doi: 10.1037//0278-6133.18.1.14. Health Psychol. 1999. PMID: 9925041

7

Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence.

Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG. Lerman C, et al. Mol Psychiatry. 2000 Mar;5(2):189-92. doi: 10.1038/sj.mp.4000672. Mol Psychiatry. 2000. PMID: 10822347

8

Nicotine metabolism and CYP2D6 phenotype in smokers.

Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, Issaq HJ, Utermahlan B, Falk RT, Shields P. Caporaso NE, et al. Among authors: lerman c. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):261-3. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303596 Clinical Trial.

9

Tryptophan hydroxylase gene variant and smoking behavior.

Lerman C, Caporaso NE, Bush A, Zheng YL, Audrain J, Main D, Shields PG. Lerman C, et al. Am J Med Genet. 2001 Aug 8;105(6):518-20. doi: 10.1002/ajmg.1476. Am J Med Genet. 2001. PMID: 11496367

10

Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.

Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Lerman C, et al. Nicotine Tob Res. 2001 Nov;3(4):353-9. doi: 10.1080/14622200110072156. Nicotine Tob Res. 2001. PMID: 11694203 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

429 results

Search Page